Transatlantic Differences in GMO Regulation

A Case Study ApproachWhen it comes to GMOs the European Union (EU) and the United States (US) have chosen strictly opposing paths, although they were confronted with the same questions and information surrounding the GMO debate. With the statement above, Dan Glickman,the former United States Secretary of Agriculture, expressed his concern about the state of public opinion on biotechnology in Europe. It is a nice illustration of some of the differences and stereotypes surrounding the topic of genetically modified organisms (GMOs): whereas, for instance, the European regulatory system is generally characterised as politicised, decentralised and precautionary, the US system is often said to be the complete opposite, namely technocratic, centralised and sound science-based.The strikingly different regulatory approaches towards GMOs have created an international debate regarding the production, cultivation and consumption of food made from or with GMOs. The different regulatory approaches employed by the EU and the US “created serious obstacles to the export of agricultural products from the United States, and in turn raised the prospect of a major international trade war over the approval and marketing of GM foods and crops” (Shaffer, 2004, p. 2). In 2003, the conflict culminated in a World Trade Organization (WTO) case filed by the US, Canada and Argentina against the EU. Inter alia, the complainants challenged the unofficial de facto moratorium of the EU on the approval of biotech products and the national safeguard measures adopted by certain Member States (WTO, 2010). In 2006, the WTO ruled that the EU was indeed breaching its obligations under the WTO Agreement on the Application of Sanitary and Phytosanitary Measures (SPS Agreement). The regulatory differences in GMO regulation between the EU and the US have triggered a debate which has attracted the attention of scholars from various different disciplines and academic backgrounds. Jasanoff, for example, uses the concept of political culture to show that the different approaches taken by the EU and the US reflect “more or less self-conscious projects of nation-building” (Jasanoff, 2007, p.7). Vogel, by contrast, examines the regulatory differences from a political scientist´s perspective proposing three interrelated factors – the intensity of public pressure, the political preference of influential policy makers, and the criteria used for risk assessment – in order to account for the transatlantic regulatory divergence of GMOs (Vogel, 2012). Also jurists like Wiener and Alemanno have engaged in the topic focusing inter alia on the application of the precautionary principle in the EU and the US, or the role of the WTO (Wiener J.B., Rogers, M.B., Hammit, J.K., Sand, P.H., 2011; Alemanno, 2010)

Regulating Innovation, Trade and Uncertain Risks - Full copy

MaRBLe Research Papers Maastricht Research-Based Learning Project (MaRBLe) Faculty of Law and Faculty of Arts and Social Sciences Maastricht University, 201